SCHEMBL921912

SCHEMBL921912

CSC(C)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL3894177 0.78
SCHEMBL11631809 0.77
SCHEMBL3004115 0.74
Ammonia Solution, Strong SCHEMBL7755676 0.72
SCHEMBL7725 0.71
SCHEMBL2556849 0.71
SCHEMBL23207477 0.70
SCHEMBL25593195 0.70
SCHEMBL11658135 0.70
SCHEMBL869211 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441758-B2 Cobalamin derivatives and their use for the treatment of diseases caused by lack of vitamin B12 supply ALBERT-LUDWIGS-UNIVERSITAET FREIBURG (DE) 2025-10-14 US disclosed
EP-4511355-A2 EFFECTIVE MEANS TO MODULATE NMDA RECEPTOR-MEDIATED TOXICITY FundaMental Pharma GmbH (DE) 2025-02-26 EP disclosed
WO-2024043020-A1 COMPOUND AND METAL EXTRACTANT 住友化学株式会社 2024-02-29 WO disclosed
EP-3777979-B1 ANTI-INFLAMMATORY COMPOUND AND PREPARATION AND USE THEREOF E NITIATE BIOPHARMACEUTICALS HANGZHOU CO LTD (CN) 2024-01-17 EP disclosed
WO-2023203254-A2 EFFECTIVE MEANS TO MODULATE NMDA RECEPTOR-MEDIATED TOXICITY FUNDAMENTAL PHARMA GMBH (DE) 2023-10-26 WO disclosed
CN-110799518-B Cobalamin derivatives and their use for the treatment of diseases caused by a deficiency of vitamin B12 supply 艾伯特-路德维格斯-弗赖堡大学 2023-07-25 CN disclosed
CN-115667254-A Compounds and compositions as bromodomain protein inhibitors 贝达药业股份有限公司 2023-01-31 CN disclosed
US-20220372064-A1 COBALAMIN DERIVATIVES AND THEIR USE FOR THE TREATMENT OF DISEASES CAUSED BY LACK OF VITAMIN B12 SUPPLY ALBERT-LUDWIGS-UNIVERSITAET FREIBURG (DE) 2022-11-24 US disclosed
US-11440886-B2 Anti-inflammatory compound, and preparation and use thereof E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. (CN) 2022-09-13 US disclosed
US-11384113-B2 Cobalamin derivatives and their use for the treatment of diseases caused by lack of vitamin B12 supply ALBERT-LUDWIGS-UNIVERSITAET-FREIBURG (DE) 2022-07-12 US disclosed
EP-0254241-A1 Pyrazolopyridine compounds, their preparation and use Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1988-01-27 EP disclosed
US-4696894-A Silver halide photographic materials containing 1,3,4-thiadiazole derivatives having a polar substituent FUJI PHOTO FILM CO., LTD. (JP) 1987-09-29 US disclosed
EP-0054233-B1 NOVEL BENZO(B)THIOPHENES, BENZO(B)FURANS, THIOCHROMANS AND CHROMANS, PROCESSES FOR THEIR PREPARATION AND ANTIMICROBIAL COMPOSITIONS CONTAINING THEM SCHERING CORPORATION (US) 1986-09-24 EP disclosed
EP-0191948-A2 Silver halide photographic materials FUJI PHOTO FILM CO., LTD. (JP) 1986-08-27 EP disclosed
EP-0054233-A1 Novel benzo(b)thiophenes, benzo(b)furans, thiochromans and chromans, processes for their preparation and antimicrobial compositions containing them SCHERING CORPORATION (US) 1982-06-23 EP disclosed
US-4080461-A PESTICIDES, FUNGICIDES SYNTEX (U.S.A.) INC. (US) 1978-03-21 US disclosed
US-4072696-A 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity SYNTEX (U.S.A.) INC. (US) 1978-02-07 US disclosed
US-4002640-A ANTIFUNGAL AGENTS SYNTEX (U.S.A.) INC. (US) 1977-01-11 US disclosed
US-3993768-A FUNGICIDES SYNTEX (U.S.A.) INC. (US) 1976-11-23 US disclosed
US-3978240-A FLAVORING LEVER BROTHERS COMPANY (US) 1976-08-31 US disclosed